Thiazides could achieve major cost savings in uncomplicated hypertensionBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7414.521-a (Published 04 September 2003) Cite this as: BMJ 2003;327:521
- Susan Mayor
Greater use of thiazides in patients with uncomplicated hypertension and with no indication for other antihypertensive agents could result in major costs savings, according to a cost minimisation analysis.
The study, by researchers at the Norwegian Directorate for Health and Social Affairs, Oslo, estimated that millions of dollars could be saved each year if thiazides were prescribed for patients with hypertension instead of dearer drugs. They reviewed the number of people being treated for hypertension in six countries—Canada, France, Germany, Norway, the United Kingdom, and the United States—and estimated the number who could be treated with thiazides.
By comparing this estimate with data …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial